Abstract
Purpose
The study aims to describe the course and management of non-infectious uveitis during pregnancy and postpartum period in European populations.
Methods
A retrospective observational study in two tertiary centers in France was performed. Pregnant patients during the follow-up of a non-infectious uveitis as well as those with new-onset uveitis were included. The medical records were analyzed with a systematic collection of the characteristics of the uveitis, the treatment and evolution of the uveitis, and the course of the pregnancy including obstetric complications.
Results
Seventy-nine pregnancies in 59 women were included: 48 patients (68 pregnancies) were followed for uveitis and 11 had a new-onset uveitis diagnosis. Most patients had idiopathic uveitis (32.2%) or sarcoid uveitis (27.1%). Among the patients followed for uveitis at the time of conception, there were 18 relapses (26.5%) requiring treatment escalation. Relapses occurred mainly in the two first trimester (n = 12) or during the postpartum period (n = 5) and were significantly associated with an active uveitis at the time of conception (OR = 9.2, 95% CI [1.57–48.4], p = 0.01). The characteristics of the new-onset uveitis were similar to those already existing before pregnancy. Obstetric complications occurred in 25 pregnancies (31.6%), mainly gestational hypertension and gestational diabetes.
Conclusion
The frequency of non-infectious uveitis relapses decreases as pregnancy progresses, in agreement with data from other non-European studies. However, multidisciplinary monitoring should be advised, especially to uncontrolled patients at the time of conception.
Similar content being viewed by others
References
Bertrand P-J, Jamilloux Y, Ecochard R et al (2019) Uveitis: autoimmunity and beyond. Autoimmun Rev 18:102351. https://doi.org/10.1016/j.autrev.2019.102351
Tsirouki T, Dastiridou A, Symeonidis C et al (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26:2–16. https://doi.org/10.1080/09273948.2016.1196713
Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmol 111:491–500. https://doi.org/10.1016/j.ophtha.2003.06.014
Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2010) The implications of autoimmunity and pregnancy. J Autoimmun 34:J287-299. https://doi.org/10.1016/j.jaut.2009.11.015
Kump LI, Cervantes-Castañeda RA, Androudi SN et al (2006) Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm 14:99–104. https://doi.org/10.1080/09273940500557027
Rabiah PK, Vitale AT (2003) Noninfectious uveitis and pregnancy. Am J Ophthalmol 136:91–98. https://doi.org/10.1016/s0002-9394(03)00110-7
Chiam NPY, Hall AJH, Stawell RJ et al (2013) The course of uveitis in pregnancy and postpartum. Br J Ophthalmol 97:1284–1288. https://doi.org/10.1136/bjophthalmol-2013-303358
Grotting LA, Papaliodis GN (2017) A review of the course and treatment of non-infectious uveitis during pregnancy. Semin Ophthalmol 32:75–81. https://doi.org/10.1080/08820538.2016.1228402
Standardization of Uveitis Nomenclature (SUN) Working Group (2021) Development of classification criteria for the uveitides. Am J Ophthalmol 228:96–105. https://doi.org/10.1016/j.ajo.2021.03.061
de Parisot A, Kodjikian L, Errera M-H et al (2017) Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol 178:176–185. https://doi.org/10.1016/j.ajo.2017.03.029
Mochizuki M, Smith JR, Takase H et al (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103:1418–1422. https://doi.org/10.1136/bjophthalmol-2018-313356
Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. https://doi.org/10.1016/j.ajo.2005.03.057
Verhagen FH, Braakenburg AM, Kremer T et al (2017) Reduced number of relapses of human leucocyte antigen-B27-associated uveitis during pregnancy. Acta Ophthalmol 95:e798–e799. https://doi.org/10.1111/aos.13387
Chiam NPY, Lim LLP (2014) Uveitis and gender: the course of uveitis in pregnancy. J Ophthalmol 2014:401915. https://doi.org/10.1155/2014/401915
Sharon Y, Adler A, Tiosano A, et al (2022) The effect of pregnancy on the course of uveitis in single and multiple pregnancies. Graefes Arch ClinExp Ophthalmol. https://doi.org/10.1007/s00417-022-05829-w
Idiopathic multifocal choroiditis and punctate inner choroidopathy: an evaluation in pregnancy — PubMed. https://pubmed.ncbi.nlm.nih.gov/34009733/. Accessed 19 Apr 2022
Burmester GR, Landewé R, Genovese MC et al (2017) Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 76:414–417. https://doi.org/10.1136/annrheumdis-2016-209322
Prieto-Peña D, Calderón-Goercke M, Adán A et al (2021) Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy. Clin Exp Rheumatol 39:105–114
Mariette X, Förger F, Abraham B et al (2018) Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis 77:228–233. https://doi.org/10.1136/annrheumdis-2017-212196
Götestam Skorpen C, Hoeltzenbein M, Tincani A et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75:795–810. https://doi.org/10.1136/annrheumdis-2015-208840
Boucheron P, Lailler G, Moutengou E, et al (2021) Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study. Eur Heart J ehab686 https://doi.org/10.1093/eurheartj/ehab686
Billionnet C, Mitanchez D, Weill A et al (2017) Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 60:636–644. https://doi.org/10.1007/s00125-017-4206-6
Chapelon Abric C, Ginsburg C, Biousse V et al (1998) Sarcoidosis and pregnancy. A retrospective study of 11 cases. Rev Med Interne 19:305–312. https://doi.org/10.1016/s0248-8663(98)80099-4
Kobak S (2020) Regression of sarcoidosis during pregnancy: case report and review of the literature. Mediterr J Rheumatol 31:416–420. https://doi.org/10.31138/mjr.31.4.416
Mayock RL, Sullivan RD, Greening RR, Jones R (1957) Sarcoidosis and pregnancy. J Am Med Assoc 164:158–163. https://doi.org/10.1001/jama.1957.02980020038008
Hadid V, Patenaude V, Oddy L, Abenhaim HA (2015) Sarcoidosis and pregnancy: obstetrical and neonatal outcomes in a population-based cohort of 7 million births. J Perinat Med 43:201–207. https://doi.org/10.1515/jpm-2014-0017
Köcher L, Rossides M, Remaeus K et al (2020) Maternal and infant outcomes in sarcoidosis pregnancy: a Swedish population-based cohort study of first births. Respir Res 21:225. https://doi.org/10.1186/s12931-020-01493-y
Author information
Authors and Affiliations
Contributions
S. G. and P. S. were the principal investigators; they conceived and designed the study. S. G. collected the data. All authors interpreted the data and approved the manuscript. S. G. and P. S. drafted the manuscript. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Comité de Protection des Personnes Sud Est IV and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The present study received approval from the local ethics committee (CPP Sud Est IV) on February 2019 (N° 19–31) and was registered on www.clinicaltrials.gov (NCT 03863782).
Informed consent
According to French law, written consent for this study was not required due to its retrospective nature.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Giorgiutti, S., Jamilloux, Y., Gerfaud-Valentin, M. et al. The course of non-infectious uveitis in pregnancy: a retrospective study of 79 pregnancies. Graefes Arch Clin Exp Ophthalmol 261, 1391–1398 (2023). https://doi.org/10.1007/s00417-022-05949-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-022-05949-3